<DOC>
	<DOCNO>NCT02843633</DOCNO>
	<brief_summary>This study aim confirm non-inferiority BioFreedom™ Drug Coated Stent Gazelle™ Bare Metal Stent arm Leaders Free study high bleeding risk patient .</brief_summary>
	<brief_title>LEADERS FREE II : BioFreedom™ Pivotal Study</brief_title>
	<detailed_description>In study patient receive BioFreedom™ Drug Coated Stent one month Dual Anti Platelet Therapy</detailed_description>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<criteria>Any indication percutaneous coronary intervention stent placement ( PCIS ) patient deem high risk bleed candidate 1 month dual antiplatelet therapy ( DAPT ) . This include candidate stable angina , silent ischemia , acute coronary syndrome ( STEMI nonSTEMI ) , nonnative lesion instent restenosis . Patients must provide write informed consent . Reasons unsuitability &gt; 1 month dual antiplatelet treatment must include one follow : 1 . Adjunctive oral anticoagulation treatment plan continue PCI 2 . Age ≥ 75 year old 3 . Baseline Hgb &lt; 11 g/dl ( anemia require transfusion 4 week prior index procedure ) 4 . Any prior intracerebral bleed 5 . Any stroke last 12 month 6 . Hospital admission bleed prior 12 month 7 . Non skin cancer diagnose treat &lt; 3 year , perceive increase risk bleed 8 . Planned daily Nonsteroidal antiinflammatory drug ( NSAID ) ( aspirin ) steroids &gt; 30 day PCI 9 . Planned surgery would require interruption DAPT ( within next 6 month ) 10 . Renal failure define : Creatinine clearance &lt; 40 ml/min 11 . Thrombocytopenia ( PLT &lt; 100,000/mm3 ) 12 . Severe chronic liver disease define : patient develop follow : variceal hemorrhage , ascites , hepatic encephalopathy jaundice 13 . Expected noncompliance prolonged DAPT medical reason 1 . Pregnant breastfeed woman 2 . Patients expect comply 1 month DAPT 3 . Patients require plan stag PCI procedure one week index procedure 4 . Procedure plan require nonstudy stent , standalone plain old balloon angioplasty ( POBA ) standalone atherectomy 5 . Active bleeding time inclusion 6 . Reference vessel diameter &lt; 2.25 &gt; 4.0mm 7 . Cardiogenic shock 8 . Compliance longterm single antiplatelet therapy unlikely 9 . A known hypersensitivity contraindication aspirin , clopidogrel ( prasugrel , ticagrelor applicable ) , stainless steel , zinc , Biolimus A9™ sensitivity contrast medium , adequately premedicated 10 . PCI previous 12 month lesion target lesion index procedure 11 . Participation another clinical trial ( 12 month index procedure ) 12 . Patients life expectancy &lt; 12 month 13 . Patients judicial protection , tutorship curatorship ( France )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
	<keyword>Drug Coated Stent</keyword>
	<keyword>Drug Eluting Stent</keyword>
</DOC>